Big Data and Artificial Intelligence for Precision Medicine in the Neuro-ICU: Bla, Bla, Bla - Neurocritical Care

These iterative design modifications and rapid prototyping are essential and have to be planned early and not during large-scale trials to avoid undermining the whole project. This step might be compared to a phase 1 or 2 trial for drug development. However, before using the new AI tool at the bedside, we need to have a large trial demonstrating an efficacy on valuable outcomes, as we are used to with phase 3 trials before adopting a new therapeutical approach. However, this stage cannot be escaped. Large-scale clinical trials are complicated and expensive activities that require meticulous preparation.